Fig. 5From: Prognostic significance of different molecular typing methods and immune status based on RNA sequencing in HR-positive and HER2-negative early-stage breast cancerImmune status and prognosis. Disease-free survival analysis based on TILs subgroups (a) and immune score (c); Distant metastasis-free survival analysis based on TILs subgroups (b) and immune score (d)Back to article page